Posted by Editoress on 07/31/09
Earlier today, the UCI advised Spanish rider Mikel Astarloza that he has been provisionally suspended. The decision to provisionally suspend Mr Astarloza was made in response to a report from the WADA accredited laboratory in Madrid indicating an Adverse Analytical Finding of Recombinant EPO in a urine sample collected from him at an out-of-competition test on 26 June 2009.
The report from the laboratory was received by the UCI yesterday (July 30th).
The provisional suspension remains in force until a hearing panel convened by the Spanish Cycling Federation determines whether Mr Astarloza has committed an anti-doping rule violation under Article 21 of the UCI Anti-Doping Rules. The hearing panel will make a decision on an applicable sanction for Mr Astarloza including his disqualification from any events, in which he competed following the collection of the sample on 26 June.
Mr Astarloza has the right to request and attend the analyses of his B sample.
Under the World Anti-Doping Code and the UCI Anti-Doping Rules, the UCI is unable to provide any additional information at this time.
UCI Press Service
Note: We will be reviewing the results of the Fantasy Tour due to this suspension, since it was announced within one week of the end of the race. Astarloza finished third on stage 8 and won stage 16. He also finished 11th overall. All of these standings will have to be revised.
|Return to Canadian Cyclist homepage | Back to Top|